Page last updated: 2024-10-27

gabexate and Esophageal Diseases

gabexate has been researched along with Esophageal Diseases in 1 studies

Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.

Esophageal Diseases: Pathological processes in the ESOPHAGUS.

Research Excerpts

ExcerptRelevanceReference
"Although Boerhaave syndrome is generally considered to have poor prognosis, conservative therapy may be effective in select cases with early detection of the perforation."1.33Boerhaave syndrome treated conservatively following early endoscopic diagnosis: a case report. ( Katsuno, A; Makino, H; Matsuda, A; Matsutani, T; Miyashita, M; Nomura, T; Sasajima, K; Sasaki, J; Tajiri, T, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Matsuda, A1
Miyashita, M1
Sasajima, K1
Nomura, T1
Makino, H1
Matsutani, T1
Katsuno, A1
Sasaki, J1
Tajiri, T1

Other Studies

1 other study available for gabexate and Esophageal Diseases

ArticleYear
Boerhaave syndrome treated conservatively following early endoscopic diagnosis: a case report.
    Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 2006, Volume: 73, Issue:6

    Topics: Adult; Anti-Bacterial Agents; Chest Pain; Combined Modality Therapy; Endoscopy, Gastrointestinal; En

2006